The European Medicines Agency (EMA) on Monday launched a pilot program intended to allow greater flexibility for sponsors of innovative medicines in developing pediatric investigation plans (PIPs).

The Department for Work and Pensions (DWP) has set the record straight regarding its position on the "set symptoms list" for Personal Independence Payment (PIP) recipients. Officials have made it ...